000			05568nam a22004215i 4500
999			_c381882 _d381882 _x1
001			381882
003			ES-MaUEC
005			20230102121937.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			220910s2022 sz | s |||| 0|eng d
020			_a9783030972363
024	7		_a10.1007/978-3-030-97236-3 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRG483.E53 _b2022 EB
245	0	0	_aEndometriosis and Adenomyosis : _bGlobal Perspectives Across the Lifespan _cedited by Engin Oral
250			_aFirst edition 2022
264		1	_aCham _bSpringer International Publishing _c2022
300			_a1 recurso en línea (XXIV, 611 páginas) _b89 ilustraciones, 73 ilustraciones a color
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_aarchivo de texto _bPDF
505	0		_aPart I. Endometriosis: An Overview -- Endometriosis in Human History -- Global Epidemiologic Data on Endometriosis -- Presumptive Causes of Endometriosis across the Lifespan -- Pathogenesis of Endometriosis: Retrograde Menstruation and Metaplasia, Inflammation, Autoimmunity, Genetics -- Classification and Clinical Staging of Endometriosis -- Diagnostic Modalities: Imaging and Markers -- Multidisciplinary Aspects of Chronic Pain without Endometriosis -- Part II. Endometriosis across the Lifespan -- Endometriosis In Utero and Early Life -- Endometriosis in Adolescence -- Endometriosis in the Reproductive Years: Fertility and Pain -- Endometriosis in Peri- and Postmenopausal Years -- Pregnancy and Obstetric Outcomes -- Part III. Miscellaneous Clinical Presentations and Management of Endometriosis -- Recurrent Endometriosis -- A Rare Entity of Extra Pelvic Endometriosis: Scar, Diaphragmatic, Pulmonary Involvement -- Fertility Preservation for Endometriosis -- Malignancy Risks Associated with Endometriosis -- Psychological Considerations in Endometriosis -- Sexual Dysfunction and Endometriosis -- Nutritional Interventions, Complementary and Alternative Medicine for Endometriosis -- Prevention of Endometriosis: Is It Possible?- How to Establish a "Center of Excellence" for Endometriosis -- Cost Estimates Associated with Diagnosis and Treatment of Endometriosis -- Part IV. Adenomyosis: An Overview -- What Is Adenomyosis?- Adenomyosis in Medicine -- Insights into Adenomyosis Development -- Classification and Staging of Adenomyosis -- Non-invasive Diagnosis of Adenomyosis: Ultrasonography and MRI -- Part V: Adenomyosis across the Lifespan -- Adenomyosis in Adolescence -- Adenomyosis in the Reproductive Years: Abnormal Uterine Bleeding, Pain, Fertility -- Pregnancy and Obstetric Outcomes in Adenomyosis -- Does Adenomyosis Increase Cancer Risk?- Part VI. Clinical Pharmaceutical Features of Drugs Used in Endometriosis and Adenomyosis Treatment -- Hormonal Therapy: Oral Contraceptives, Progestins, Danazol, Aromatase Inhibitors -- GnRH Agonists and Antagonists -- Part VII. Guidelines and Future Prospects for Endometriosis and Adenomyosis -- Recent Guidelines on Endometriosis and Adenomyosis -- The Future of Endometriosis and Adenomyosis Research.
520			_aAlthough endometriosis and adenomyosis are often assessed under the same umbrella, the epidemiology, clinical manifestations and management strategies of endometriosis and adenomyosis occur differently during the life cycle of a woman. Endometriosis can be diagnosed at many points across the lifespan, including adolescence and the climacterium, as well as pregnancy. Being associated with potential adverse health effects, different clinical presentations requiring different therapeutic approaches render it imperative to tailor management strategies for each period of the lifespan: in utero and early life, puberty and adolescence, reproductive years, pregnancy, late reproductive age, and the menopause. This book provides comprehensive insight into the general aspects, diagnosis and treatment modalities of endometriosis and adenomyosis in all stages of a woman's life - a unique element of its approach. Thematic sections discuss the basics of diagnosis and management of both endometriosis and adenomyosis from birth through menopause, including aspects of fertility preservation, sexual dysfunction, psychological considerations and prevention. The current pharmaceutical approaches and efficacy are presented, including progestins, aromatase inhibitors and GnRH agonists and antagonists. The final section provides current practice guidelines for the management of both conditions as well as an investigation into future research and clinical strategies. Taking a truly global perspective, Endometriosis and Adenomyosis will be a valuable resource for reproductive endocrinologists, infertility specialists and obstetricians and gynecologists worldwide.
988			_aSpringer_Medicine_2022
650		7	_2embne _9405574 _aEndometriosis
700	1		_aOral, Engin _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
773	0		_tSpringer Nature eBook
776	0	8	_iPrinted edition: _z9783030972356
776	0	8	_iPrinted edition: _z9783030972370
776	0	8	_iPrinted edition: _z9783030972387
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-97236-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b07/2022 _dz _eIG _zSI